27882558|t|Effects of voice-sparing cricotracheal resection on phonation in women
27882558|a|Individuals with idiopathic subglottic stenosis (SGS) are at risk for voice disorders prior to and following surgical management. This study examined the nature and severity of voice disorders in patients with SGS before and after a revised cricotracheal resection (CTR) procedure designed to minimize adverse effects on voice function. Eleven women with idiopathic SGS provided presurgical and postsurgical audio recordings. Voice Handicap Index (VHI) scores were also collected. Cepstral, signal-to-noise, periodicity, and fundamental frequency (F0) analyses were undertaken for connected speech and sustained vowel samples. Listeners made auditory - perceptual ratings of overall quality and monotonicity. Paired samples statistical analyses revealed that mean F0 decreased from 215 Hz (standard deviation [SD] = 40 Hz) to 201 Hz (SD = 65 Hz) following surgery. In general, VHI scores decreased after surgery. Voice disorder severity based on the Cepstral Spectral Index of Dysphonia (KayPentax, Montvale, NJ) for sustained vowels decreased (improved) from 41 (SD = 41) to 25 (SD = 21) points; no change was observed for connected speech. Semitone SD (2.2 semitones) did not change from pre- to posttreatment. Auditory - perceptual ratings demonstrated similar results. These preliminary results indicate that this revised CTR procedure is promising in minimizing adverse voice effects while offering a longer-term surgical outcome for SGS. Further research is needed to determine causal factors for pretreatment voice disorders, as well as to optimize treatments in this population. 4. Laryngoscope, 2016.
27882558	0	10	Effects of	T080	C1704420
27882558	25	48	cricotracheal resection	T061	C4291730
27882558	52	61	phonation	T042	C0031577
27882558	65	70	women	T098	C0043210
27882558	71	82	Individuals	T098	C0027361
27882558	88	118	idiopathic subglottic stenosis	T047	C2931158
27882558	120	123	SGS	T047	C2931158
27882558	132	136	risk	T078	C0035647
27882558	141	156	voice disorders	T047	C0042940
27882558	170	179	following	T079	C0332282
27882558	180	199	surgical management	T058	C1515089
27882558	206	211	study	T062	C2603343
27882558	212	220	examined	T033	C0332128
27882558	236	244	severity	T080	C0439793
27882558	248	263	voice disorders	T047	C0042940
27882558	267	275	patients	T101	C0030705
27882558	281	284	SGS	T047	C2931158
27882558	312	351	cricotracheal resection (CTR) procedure	T061	C4291730
27882558	352	360	designed	T052	C1707689
27882558	373	388	adverse effects	T080	C1280500
27882558	392	406	voice function	T039	C0541586
27882558	415	420	women	T098	C0043210
27882558	426	440	idiopathic SGS	T047	C2931158
27882558	441	449	provided	T052	C1999230
27882558	450	461	presurgical	T079	C0445204
27882558	466	478	postsurgical	T079	C0032790
27882558	479	495	audio recordings	UnknownType	C0681505
27882558	497	530	Voice Handicap Index (VHI) scores	T201	C3472512
27882558	541	550	collected	T169	C1516698
27882558	562	577	signal-to-noise	T081	C2986823
27882558	579	590	periodicity	T079	C0031084
27882558	596	617	fundamental frequency	T079	C0439603
27882558	619	621	F0	T079	C0439603
27882558	652	668	connected speech	T033	C4280380
27882558	673	682	sustained	T169	C0443318
27882558	683	696	vowel samples	T170	C0871955
27882558	698	707	Listeners	T098	C1257890
27882558	713	721	auditory	T169	C0439825
27882558	724	734	perceptual	T041	C0030971
27882558	735	742	ratings	T052	C0871208
27882558	754	761	quality	T080	C0332306
27882558	766	778	monotonicity	UnknownType	C0241704
27882558	780	815	Paired samples statistical analyses	T062	C0871424
27882558	816	824	revealed	T080	C0443289
27882558	835	837	F0	T079	C0439603
27882558	838	847	decreased	T081	C0205216
27882558	861	879	standard deviation	T081	C0871420
27882558	881	883	SD	T081	C0871420
27882558	905	907	SD	T081	C0871420
27882558	917	926	following	T079	C0332282
27882558	927	934	surgery	T061	C0543467
27882558	948	958	VHI scores	T201	C3472512
27882558	959	968	decreased	T081	C0205216
27882558	975	982	surgery	T061	C0543467
27882558	984	998	Voice disorder	T047	C0042940
27882558	999	1007	severity	T080	C0392364
27882558	1021	1044	Cepstral Spectral Index	T170	C0918012
27882558	1048	1057	Dysphonia	T048	C1527344
27882558	1059	1068	KayPentax	T073,T092	C0683757
27882558	1070	1078	Montvale	UnknownType	C0681784
27882558	1080	1082	NJ	T083	C0027971
27882558	1088	1097	sustained	T169	C0443318
27882558	1098	1104	vowels	T170	C0871955
27882558	1105	1114	decreased	T081	C0205216
27882558	1116	1124	improved	T033	C0184511
27882558	1135	1137	SD	T081	C0871420
27882558	1151	1153	SD	T081	C0871420
27882558	1168	1177	no change	T033	C0442739
27882558	1182	1190	observed	T169	C1441672
27882558	1195	1211	connected speech	T033	C4280380
27882558	1222	1224	SD	T081	C0871420
27882558	1261	1265	pre-	T079	C2709094
27882558	1269	1282	posttreatment	T079	C2709088
27882558	1284	1292	Auditory	T169	C0439825
27882558	1295	1305	perceptual	T041	C0030971
27882558	1306	1313	ratings	T052	C0871208
27882558	1335	1342	results	T169	C1274040
27882558	1350	1369	preliminary results	T078	C1548161
27882558	1397	1410	CTR procedure	T061	C4291730
27882558	1446	1451	voice	T040	C0042939
27882558	1452	1459	effects	T080	C1280500
27882558	1477	1488	longer-term	T079	C0443252
27882558	1489	1505	surgical outcome	T080	C0085415
27882558	1510	1513	SGS	T047	C2931158
27882558	1523	1531	research	T062	C0035168
27882558	1562	1569	factors	T169	C1521761
27882558	1574	1586	pretreatment	T079	C2709094
27882558	1587	1602	voice disorders	T047	C0042940
27882558	1627	1637	treatments	T061	C0087111
27882558	1646	1656	population	T098	C1257890